Instrument Inactif

Cours Fresenius Kabi Oncology Ltd

Actions

Cours en clôture NSE India S.E. Autres places de cotation
- ^INR	-

AstraZeneca sells rights to anaesthetics for up to $770 million	09/06/16
Fresenius SE KGaA : Kabi sells German oncology compounding business	16/02/15
Fresenius Kabi Oncology Ltd : India revokes GSK cancer drug patent in latest Big Pharma blow	02/08/13
Fresenius Kabi Oncology Ltd : India board revokes GSK patent on breast cancer drug Tykerb	02/08/13

Dirigeants	Titre	Age	Depuis
Arvind Kumar Sharma CEO	Chief Executive Officer	-	01/07/18
Rahul Sharma DFI	Director of Finance/CFO	-	-
Maria Gobbi CHM	Chairman	-	13/11/14

Administrateurs	Titre	Age	Depuis
Michael Schönhofen BRD	Director/Board Member	63	11/08/08
Nikhil Kulshreshtha BRD	Director/Board Member	-	21/07/07
Maria Gobbi CHM	Chairman	-	13/11/14

Secteur

	Varia. 1 janv.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-2,63 %	102 Md
REGENERON PHARMACEUTICALS, INC.	+1,62 %	96,29 Md
ARGENX SE	+1,92 %	22,18 Md
BIONTECH SE	-16,67 %	21,2 Md
GENMAB A/S	-7,77 %	18,31 Md
WUXI APPTEC CO., LTD.	-38,74 %	17,38 Md
BEIGENE, LTD.	-13,21 %	16,36 Md
NEUROCRINE BIOSCIENCES, INC.	+5,41 %	13,97 Md
SAREPTA THERAPEUTICS, INC.	+33,57 %	12,17 Md